에서 실시간으로 운영 중이에요! 자세히 알아보기
ZBH 아이콘

Zimmer Biomet
ZBH

94.98 USD
+0.60
0.64%
장 마감 시점 업데이트됨 10월 16일 PM 4:00 EDT
프리마켓
시간외 거래
94.25
-0.73
0.77%
1일
0.64%
5일
6.38%
1개월
-1.86%
3개월
1.31%
6개월
0.21%
연초 이후
5.51%
1년
-4.94%
5년
-32.52%
10년
-22.74%
 

소개: Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

직원 수: 17,000

건강관리 의료기기

뉴스

긍정적
중립
부정적
투자 심리 3개월
긍정적 50%
중립 50%
부정적 0%
중립
PRNewsWire
3일 전
ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT
Multi-Year Extension to Help Accelerate Adoption of Wireless, Handheld TMINI® System for Use with Zimmer Biomet's Persona® Knee System FREMONT, Calif. and WARSAW, Ind.
ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT
긍정적
Zacks Investment Research
4일 전
Should Value Investors Buy Zimmer Biomet (ZBH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Zimmer Biomet (ZBH) Stock?
긍정적
Zacks Investment Research
9일 전
Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy?
중립
PRNewsWire
10일 전
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results
WARSAW, Ind., Oct. 6, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its third quarter earnings conference call will be webcast on Wednesday, November 4, 2026, at 8:30 a.m.
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results
긍정적
Zacks Investment Research
29일 전
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
중립
PRNewsWire
지난달
Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial Transformation
Gary Campbell promoted to President, Americas Brian Hatcher promoted to President, Recon, S.E.T., CMFT, Neuro and Biosurgery Bradley Kessler promoted to President, Americas – Robotics, Technology and Data WARSAW, Ind.
Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial Transformation
긍정적
Zacks Investment Research
지난달
Why Is Zimmer (ZBH) Up 1.8% Since Last Earnings Report?
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
Why Is Zimmer (ZBH) Up 1.8% Since Last Earnings Report?
긍정적
Seeking Alpha
지난달
Zimmer Biomet - Showing Signs Of Life
Zimmer Biomet is seeing structural constant currency sales growth appear. This is driven by transformation factors, R&D and M&A efforts. Earnings growth is lagging sales, but this hopefully should catch up soon.
Zimmer Biomet - Showing Signs Of Life
긍정적
Zacks Investment Research
지난달
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
중립
PRNewsWire
지난달
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026
WARSAW, Ind., Aug. 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2026.
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026
뉴스 순위 보기
Lightweight Charts™를 사용해 가격 차트를 구현했어요.